Država: Australija
Jezik: engleski
Izvor: APVMA (Australian Pesticides and Veterinary Medicines Authority)
BORDETELLA BRONCHISEPTICA KILLED VACCINE
Boehringer Ingelheim Animal Health Australia Pty. Ltd.
vaccine - canine Bordetella(20ug/mL)
MISC. VACCINES OR ANTI SERA
BORDETELLA BRONCHISEPTICA KILLED VACCINE VACCINE-MICROBIAL Active 0.0 P
25 x 1mL; Syringe
VM - Veterinary Medicine
DOG | BITCH | CASTRATE | PUPPY
IMMUNOTHERAPY
BORDETELLA BRONCHISEPTICA | CANINE COUGH SYNDROME | INFECTIOUS TRACHEOBRONCHITIS
Poison schedule: 0; Withholding period: WHP:N/A; Host/pest details: DOG: [BORDETELLA BRONCHISEPTICA]; Poison schedule: 0; Withholding period: ; Host/pest details: DOG: [BORDETELLA BRONCHISEPTICA]; For the immunisation of dogs against Bordetella bronchiseptica infection, a contributing factor to the canine cough syndrome.For use only by or under the direction of a registered veterinary surgeon. This product should not be used in dogs when they are incubating an infectious disease, seriously debilitated by another infectious disease, parasitic infestation, malnutrition...
Registered
2023-07-01
Protech BB Bordetella bronchiseptica Killed Vaccine APVMA54951 Page 1 of 5 20 June 2014 FOR ANIMAL TREATMENT ONLY PROTECH®BB Syringe label BORDETELLA BRONCHISEPTICA KILLED VACCINE Contents: 1 dose (1 mL) To be used by, or under the direction of a registered veterinary surgeon. READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT. Contents must be left in outer package until immediately before use. SHAKE GENTLY BEFORE USE. Store between 2-S"C. Do not freeze. Protect from light. APVMA 54951/62963 Batch No.: Expiry: Boehringer lngelheim + RLP Approved Protech BB Bordetella bronchiseptica Killed Vaccine APVMA54951 Page 2 of 5 20 June 2014 Tray label - 25 FOR ANIMAL TREATMENT ONLY PROTECH® BB BORDETEL/A BRONCHISEPTICA KILLED VACCINE ACTIVE CONSTITUENT: An inactivated vaccine prepared from a cell-free extract of Bordetella bronchiseptica (20 ~glmL) For the immunisation of dogs against Bordetella bronchiseptica infection, a contributing factor to the canine cough syndrome. Contents: 25 single dose syringes READ ENCLOSED LEAFLET BEFORE USING THIS PRODUCT TO BE USED BY, OR UNDER THE DIRECTION OF A REGISTERED VETERINARY SURGEON. Contents must be left in outer package until immediately before use. SHAKE GENTLY BEFORE USE. Dose: A 1 mL dose (one syringe) is recommended for dogs of all ages. The vaccine is injected subcutaneously. Store between 2-B'C. Do not freeze. Protect from light. APVMA No. 54951/62963 Batch No.: Expiry: Protech® BB is a registered trademark of Boehringer lngelheim Vetmedica Inc.- used under license. Please recycle leaflet, label and tray only. Boehringer lngelheim FOR ANIMAL TREATMENT ONLY PROTECH®BB Protech BB Bordetella bronchiseptica Killed Vaccine APVMA 54951 Page 3 of 5 20 June 2014 Carton label - 25 BORDETELLA BRONCHISEPTICA KILLED VACCINE ACTIVE CONSTITUENT: An inactivated vaccine prepared from a cell-free extract of Bordeteffa bronchiseptica (20 ~g/mL) For the immunisation of dogs against Bordeteffa bronchiseptica infection, a contributing factor to the canine cough syndrome. Contents: 25 sin Pročitajte cijeli dokument
CS: 1.7.2 Page: 1 MATERIAL SAFETY DATA SHEET 4 of Infosafe No™ LQ08B August 2011 ISSUED by BOEHRING Issue Date : PROTECH® BB BORDETELLA BRONCHISEPTICA KILLED VACCINE Product Name : Not classified as hazardous 1. IDENTIFICATION OF THE MATERIAL AND SUPPLIER PROTECH® BB BORDETELLA BRONCHISEPTICA KILLED VACCINE PRODUCT NAME Boehringer Ingelheim Pty. Limited COMPANY NAME 78 Waterloo Rd North Ryde NSW 2113 Australia ADDRESS 1800 038 037 EMERGENCY TEL. Tel: 1800 038 037 Fax: +61 2 8875 8715 TELEPHONE/FAX NUMBER animalhealth.au@boehringer-ingelheim.com EMAIL For the immunisation of dogs against Bordetella bronchiseptica (canine cough). RECOMMENDED USE 2. HAZARDS IDENTIFICATION Not classified as hazardous NON-HAZARDOUS SUBSTANCE. NON-DANGEROUS GOODS. Hazard classification according to the criteria of NOHSC. Dangerous goods classification according to the Australia Dangerous Goods Code. HAZARD CLASSIFICATION 3. COMPOSITION/INFORMATION ON INGREDIENTS Water suspension of killed Bordetella bronchiseptica INFORMATION ON COMPOSITION NAME CAS PROPORTION INGREDIENTS Ingredients determined not to be hazardous - 100 % 4. FIRST AID MEASURES No special precautions required. However, if inhaled, remove affected person from contaminated area. Keep at rest until recovered. If symptoms persist seek medical attention. INHALATION Do not induce vomiting. Wash out mouth thoroughly with water. If symptoms develop seek medical attention. INGESTION Wash affected area thoroughly with soap and water. If symptoms develop seek medical attention. Self-Injection: Accidental self injection may lead to an inflammatory response and medical advice should be sought on the management of deep injections, particularly those near a joint or associated with bruising. If possible the application of gentle squeezing pressure with absorbent material (e.g. facial tissues) at the injection site will swab up unabsorbed vaccine. Strong squeezing of the site should be avoided. The damaged area should be thoroughly cleansed and a topical antiseptic applied. SKIN If Pročitajte cijeli dokument
Protech® BB ABCD Composition An inactivated vaccine prepared from a cell-free extract of Bordetella bronchiseptica (20 mg/mL). An aluminium salt is included to enhance the response to vaccination and to increase the duration of immunity. Thiomersal 0.1 mg/mL is added as a preservative. Indication The vaccine is used for the immunisation of dogs against colonisation of the upper and lower respiratory tract, nose and throat with Bordetella bronchiseptica. Directions for Use To be used by, or under the direction of a registered veterinary surgeon. Contents must be left in outer package until immediately before use. Shake gently before use. Precautions Protech® BB should not be used in dogs when they are: 1. Incubating an infectious disease 2. Seriously debilitated by another infectious disease, parasitic infestation or malnutrition; or 3. Under treatment with immunosuppressive drugs. Side Effects As Protech® BB is an inactivated vaccine, untoward systemic effects are uncommon and the vaccine may be used in pregnant bitches. Careful palpation of the site of injection may reveal a small fibrous nodule in some dogs about a week after vaccination. This nodule will regress, becoming impalpable within two to six weeks. In a very few small, smooth-coated dogs a nodule may be visible for a limited period. Some animals may show transient post-vaccination reactions including injection site pain, lethargy and/or vomiting. Systemic allergic reactions such as anaphylaxis are thought to occur rarely with all vaccines and may require appropriate treatment. Systemic hypersensitivity reactions, mainly characterised by urticaria and facial oedema, have also been reported, particularly in animals receiving a second injection of Protech® BB 4 to 8 weeks after the first injection. Premedication with antihistamine may be indicated in animals at risk. Dosage and Administration The vaccine is injected subcutaneously. A 1 mL dose (one syringe) is recommended for dogs of all ages. Gentle massage at the site of injection will help to di Pročitajte cijeli dokument